OSTX
AMEX
$1.51
OS Therapies Inc (OSTX)
OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs, particularly in neurological disorders. Utilizing its proprietary drug development technologies, the company is advancing a robust pipeline designed to enhance patient outcomes and quality of life. With a strong emphasis on research excellence and a strategic focus on targeted therapeutic areas, OS Therapies presents an attractive opportunity for institutional investors aiming to engage with transformative advancements in the evolving biotech sector.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $8.92 (+490.73%)
Market Cap
$61M
Free Cash Flow Yield
-25.23%
Beta (5Y)
1.01
Price Chart
Valuation
Market Cap$61M
Forward P/E1.66
P/B13.65
Profitability
EBITDA-$33M
EPS-$0.99
Financial Health
Free Cash Flow Yield-25.23%
Growth & Risk
Beta (5Y)1.01
Sharpe Ratio0.19